SANDY SARGENT: Open Payments
NPI 1952694861 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,330 in 145 payments from 24 companies in 2025. Trend: 2023 $2,418 · 2024 $2,892 · 2025 $3,330
Food & beverage: $3,330
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $477 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $271 |
| Janssen Biotech, Inc. | 14 | $265 |
| Ardelyx, Inc. | 10 | $257 |
| Madrigal Pharmaceuticals | 5 | $230 |
| GENZYME CORPORATION | 7 | $225 |
| QOL Medical, LLC | 9 | $218 |
| Gilead Sciences, Inc. | 10 | $207 |
| Lilly USA, LLC | 9 | $174 |
| INTUITIVE SURGICAL, INC. | 1 | $127 |
Products named: RINVOQ, DUPIXENT, TREMFYA, IBSRELA, REZDIFFRA, ENTYVIO, Sucraid, OMVOH.
Industry payments across AZ — which companies pay providers there.
